Eloxx Pharmaceuticals, Inc. (ELOX) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Eloxx Pharmaceuticals, Inc. (ELOX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $95.3M, listed on NASDAQ, employing roughly 10 people, carrying a beta of -24.60 to the broader market. Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical firm that specializes in developing therapeutic solutions through ribosome modulation. Led by Sumit Aggarwal, public since 2026-06-09.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for ELOX as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →